Open AccessFentanyl Inhibits Lung Cancer Viability and Invasion via Upregulation of miR-331-3p and Repression of HDAC5
Author(s) -
Gong Shouliang,
Ying Liang,
Yonggang Fan,
Zhenchang Sun
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s281095
Subject(s) - viability assay , cancer research , downregulation and upregulation , medicine , lung cancer , histone deacetylase 5 , microrna , a549 cell , cell culture , western blot , biology , pharmacology , oncology , histone deacetylase , histone , biochemistry , genetics , gene
Non-small cell lung cancer (NSCLC) accounts for more than 80% of lung cancer cases and remains the primary cause of cancer-related deaths worldwide. Fentanyl is a commonly utilized anesthetic during the process of tumor resection, and exhibits inhibitory effects on the progression of numerous cancer types, including pancreatic cancer, colorectal cancer and gastric cancer. However, the effects of fentanyl on the cell viability and invasion of NSCLC has not been investigated. Current study aimed to investigate the effects and the mechanisms underlying the effects of fentanyl on NSCLC.